Andson Biotechnology is building novel process analytical technologies (PATs) for application to modern biopharmaceutical workflows. Andson is leveraging novel approaches to inline and at-line mass spectrometric analysis to enable discovery, development, and process improvement with advanced analytics.
We are still pre-launch, but we are open to exploring how we can work together as we deploy our first product. If you are developing or producing any type of bio-based therapeutic we want to help you! Our technology can provide unparalleled process insight for novel quality indicators, new process understanding, and improved outcomes. Get in touch at info@andsonbiotech.com
We are still pre-launch, but we are open to exploring how we can work together as we deploy our first product. If you are developing or producing any type of bio-based therapeutic we want to help you! Our technology can provide unparalleled process insight for novel quality indicators, new process understanding, and improved outcomes. Get in touch at info@andsonbiotech.com
Location: South Africa, North West, Atlanta
Employees: 1-10
Founded date: 2021
Investors 5
| Date | Name | Website |
| - | BioTools I... | biotoolsin... |
| - | Georgia Re... | gra.org |
| 09.02.2022 | Y Combinat... | ycombinato... |
| - | Phase Two ... | phasetwo.v... |
| - | Merck Digi... | mds.studio |
Mentions in press and media 3
| Date | Title | Description |
| 19.12.2022 | Merck Digital Sciences Studio Announces the Launch of its First Cohort | NEWARK, N.J. (PRWEB) December 19, 2022 On Friday December 16, Merck (NYSE: MRK) today announced the launch of their first biopharmaceutical cohort through the Merck Digital Sciences Studio (MDSS), a collaboration between Merck, Microsoft fo... |
| - | Andson Biotech | “Simplify your mass spec sample preparation with our next-generation platform.” |
| - | Andson Biotech | “Andson Biotech” |